129 related articles for article (PubMed ID: 33352323)
41. Case report: a COVID-19 reactivation case.
Fehdi MA; Erragh A; Zerhouni A; Aissaoui O; Nsiri A; Alharrar R
Pan Afr Med J; 2020; 35(Suppl 2):35. PubMed ID: 33623560
[TBL] [Abstract][Full Text] [Related]
42. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study.
Grasselli G; Tonetti T; Protti A; Langer T; Girardis M; Bellani G; Laffey J; Carrafiello G; Carsana L; Rizzuto C; Zanella A; Scaravilli V; Pizzilli G; Grieco DL; Di Meglio L; de Pascale G; Lanza E; Monteduro F; Zompatori M; Filippini C; Locatelli F; Cecconi M; Fumagalli R; Nava S; Vincent JL; Antonelli M; Slutsky AS; Pesenti A; Ranieri VM;
Lancet Respir Med; 2020 Dec; 8(12):1201-1208. PubMed ID: 32861276
[TBL] [Abstract][Full Text] [Related]
43. Metformin in acute respiratory distress syndrome: An opinion.
Uddin MA; Akhter MS; Kubra KT; Siejka A; Barabutis N
Exp Gerontol; 2021 Mar; 145():111197. PubMed ID: 33310152
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
[TBL] [Abstract][Full Text] [Related]
45. Comparison of the Clinical Course of COVID-19 Pneumonia and Acute Respiratory Distress Syndrome in 2 Passengers from the Cruise Ship Diamond Princess in February 2020.
Matsumura K; Toyoda Y; Matsumoto S; Kawai Y; Mori T; Omasa K; Fukada T; Yamada M; Kazamaki T; Furugori S; Hiroe N; Senoo S; Shimizu M; Funabiki T; Yamazaki M
Am J Case Rep; 2020 Aug; 21():e926835. PubMed ID: 32811804
[TBL] [Abstract][Full Text] [Related]
46. COVID-19 Acute Respiratory Distress Syndrome and Pulmonary Embolism: A Case Report of Nebulized Nitroglycerin and Systemic Thrombolysis For Right Ventricular Failure.
Karfunkle B; Gill J; Shirey S; Gordon R
J Emerg Med; 2021 Nov; 61(5):e103-e107. PubMed ID: 34479748
[TBL] [Abstract][Full Text] [Related]
47. Risk Factors and a Scoring System to Predict ARDS in Patients with COVID-19 Pneumonia in Korea: A Multicenter Cohort Study.
Seo JW; Kim SE; Choi EY; Hong KS; Oh TH; Kim UJ; Kang SJ; Park KH; Jung SI; Kim DY; Yun NR; Kim DM; Kim HP; Hur J; Jang HC
Dis Markers; 2021; 2021():8821697. PubMed ID: 33897912
[TBL] [Abstract][Full Text] [Related]
48. [Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome].
Pan C; Xie JF; Qiu HB; Yang Y
Zhonghua Shao Shang Za Zhi; 2020 May; 36(5):330-333. PubMed ID: 32456368
[TBL] [Abstract][Full Text] [Related]
49. Systemic Thrombolysis as Initial Treatment of COVID-19 Associated Acute Aortoiliac and Lower Extremity Arterial Thrombosis.
Patel P; Yu Y; Zia S; Padberg F; Curi M; Huang J
Ann Vasc Surg; 2021 Jan; 70():297-301. PubMed ID: 32861850
[TBL] [Abstract][Full Text] [Related]
50. A case of acute disseminate encephalomyelitis after SARS-CoV-2 related acute respiratory distress syndrome.
Fitouchi S; Heger B; Kremer L; Kremer S; Ohlmann P
J Neuroradiol; 2021 Nov; 48(6):464-465. PubMed ID: 33220390
[No Abstract] [Full Text] [Related]
51. Understanding the Potential Role of Abrocitinib in the Time of SARS-CoV-2.
Uppal SK; Kearns DG; Chat VS; Wu JJ
J Drugs Dermatol; 2021 Jul; 20(7):806. PubMed ID: 34232002
[No Abstract] [Full Text] [Related]
52. SARS-CoV-2-Related Acute Respiratory Distress Syndrome Uncovers a Patient with Severe Combined Immunodeficiency Disease.
Al-Saud B; Hazzazi KM; Mohammed R; Al Najjar A; Al Hazmi T; Monies D; Alkuraya FS
J Clin Immunol; 2021 Oct; 41(7):1507-1510. PubMed ID: 34173127
[No Abstract] [Full Text] [Related]
53. Right ventricular failure is strongly associated with mortality in patients with moderate-to-severe COVID-19-related ARDS and appears related to respiratory worsening.
Evrard B; Goudelin M; Giraudeau B; François B; Vignon P
Intensive Care Med; 2022 Jun; 48(6):765-767. PubMed ID: 35552780
[No Abstract] [Full Text] [Related]
54. Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial.
Rashidi F; Barco S; Rezaeifar P; Sadeghipour P; Ghodrati S; Bakhshandeh H; Mousavi-Aghdas SA; Sadeghi A; Sharifi A; Valizadeh H; Mikaeili H; Rafiee F; Navarbaf Z; Farajian G; Mahmoodpoor A; Bikdeli B; Ansarin K
Thromb Res; 2022 Aug; 216():125-128. PubMed ID: 34969528
[No Abstract] [Full Text] [Related]
55. Acute cor pulmonale in ARDS.
Vieillard-Baron A; Price LC; Matthay MA
Intensive Care Med; 2013 Oct; 39(10):1836-8. PubMed ID: 23907498
[No Abstract] [Full Text] [Related]
56. Severe Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19: A Regional Factor.
Baggio JAO; Exel AL; Calles ACDN; Minatel V
Arq Bras Cardiol; 2021 Nov; 117(5):976-977. PubMed ID: 34817006
[No Abstract] [Full Text] [Related]
57. Can acute respiratory distress syndrome be treated?
Christman JW; Karpurapu M; Pei D
Future Med Chem; 2021 Apr; 13(8):687-690. PubMed ID: 33724874
[No Abstract] [Full Text] [Related]
58. Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19.
Carlet J; Payen D; Opal SM
Lancet; 2020 Oct; 396(10259):e61-e62. PubMed ID: 33045189
[No Abstract] [Full Text] [Related]
59. [Not Available].
Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
CMAJ; 2020 Nov; 192(47):E1571-E1584. PubMed ID: 33229355
[TBL] [Abstract][Full Text] [Related]
60. Therapeutic Potential of Targeting Plasminogen Activator Inhibitor-1 in COVID-19.
Kellici TF; Pilka ES; Bodkin MJ
Trends Pharmacol Sci; 2021 Jun; 42(6):431-433. PubMed ID: 33867130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
